Titan Medical recently declared that it has entered into partnership with Clinique Générale-Beaulieu (CGB), a Geneva-based medical clinic, by signing a non-binding memorandum of understanding (MOU) with the same.
As per the terms of the MOU, Titan’s Amadeus Next Generation Robotic Surgical technologies will be evaluated by CGB, followed by presenting the company with the right feedback.
The President of Titan Medical, Dr. Reiza Rayman says that the affiliation with Clinique Générale-Beaulieu will contribute to the future advancements and global commercialization of Titan. With emerging interest in robotic surgery and the recent affiliation with CGB, Titan anticipates expanding its operation across several countries. As Clinique Générale-Beaulieu team has over a decade of experience with robotic surgery, the global commercialization of Amadeus will be promoted.
Established in August 1899, the Clinique Générale-Beaulieu employs over 450 staff, credited with 600 licensed physicians. Totally 134 beds are available at the clinic. Globally reputed six specialty centers included in the facilities are The Assisted Reproductive Technologies (ART) Center; The Institute of Radiology; The Institute of Nuclear Medicine; The Physiotherapy and Functional Rehabilitation Center ; The Robot-Assisted Laparoscopic Surgery Center; and The Maternity Unit.
Titan Medical, a Canadian company is committed to the expansion and commercialization of robotic surgical technologies. A present, the company develops Amadeus Composer, a surgical system incorporated with specialized external robot and versatile instruments for surgeons. Titan’s Amadeus Maestro is the advanced 4-armed robotic surgical system is based on the Titan True Touch Technology, ideal for surgical procedures in large spaces.
Source: http://www.titanmedicalinc.com/